Human papillomavirus testing and screening
Authors:
- L.A. DennyLDL.A. Denny
- T.C. WrightTWT.C. Wright
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 19 (4) , 501-515
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for ScreeningObstetrics & Gynecology, 2004
- Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patientsBritish Journal of Cancer, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA‐positive, cytologically negative womenCancer, 2002
- Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are ReproducibleJournal of Clinical Microbiology, 2002
- Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized TrialJNCI: Journal of the National Cancer Institute, 2000
- HPV testing in primary screening of older womenBritish Journal of Cancer, 1999
- Short-term fluctuations in the detection of cervical human papillomavirus DNAObstetrics & Gynecology, 1996
- Variability of Human Papillomavirus DNA Testing in a Longitudinal Cohort of Young WomenObstetrics & Gynecology, 1993
- TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMESThe Lancet, 1987